Concomitant Liver Biopsy During Bariatric Surgery: No Increase in Major Complications or Readmissions but Associated with Higher Transfusion Requirements - An Analysis of the MBSAQIP Database
After adjusting for patient factors, concomitant liver biopsy during bariatric surgery does not independently increase the risk of major complications (Clavien-Dindo grade III and IV), readmission, or mortality. However, it is associated with increased bleeding and transfusion complications. These findings support that liver biopsy can be performed during bariatric surgery, though clinicians should be prepared for increased bleeding-related risks and blood product utilization.
Authors
- Alfredo D. Guerrón (ORCID: https://orcid.org/0000-0002-4632-1681)
- Mélissa Wills (ORCID: https://orcid.org/0000-0003-4414-0446)
- Andrew T. Strong (ORCID: https://orcid.org/0000-0001-8664-244X)
- Juan S. Barajas‐Gamboa (ORCID: https://orcid.org/0000-0003-4158-4893)
- Gustavo Romero‐Velez (ORCID: https://orcid.org/0000-0002-9762-3698)
- Valentin Mocanu (ORCID: https://orcid.org/0000-0001-7855-6242)
- John Rodriguez
- Thomas H. Shin (ORCID: https://orcid.org/0000-0003-2076-270X)
- Jerry T. Dang (ORCID: https://orcid.org/0000-0001-8659-0934)
- Matthew T. Allemang (ORCID: https://orcid.org/0000-0002-4902-9539)
- Matthew Kroh (ORCID: https://orcid.org/0000-0002-0305-1503)
- Ricard Corcelles (ORCID: https://orcid.org/0000-0002-8612-4770)
- Salvador Navarrete
- Kayanne Khoury
Institutions
- Cleveland Clinic (US)
- Royal College of Surgeons in Ireland - Bahrain (BH)
- Cleveland Clinic Lerner College of Medicine (US)
- Abu Dhabi Health Services (AE)
- University of Virginia (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Obesity Surgery
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1007/s11695-025-08267-9
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00